These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 1126465

  • 1. Effects of postovulatory estradiol benzoate administration on women's ovarian function.
    Oriol-Bosch A, Cortés J.
    Fertil Steril; 1975 May; 26(5):405-12. PubMed ID: 1126465
    [Abstract] [Full Text] [Related]

  • 2. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI, Das RP, Madoiya KK, Jain AK, Roy S.
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [Abstract] [Full Text] [Related]

  • 3. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [Abstract] [Full Text] [Related]

  • 4. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
    Cameron IT, Baird DT.
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL, Sweeting VM, Hillier H, Baird DT.
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-tubal sterilization problems correlated with ovarian steroidogenesis.
    Cattanach JF, Milne BJ.
    Contraception; 1988 Nov; 38(5):541-50. PubMed ID: 3197418
    [Abstract] [Full Text] [Related]

  • 10. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M.
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [Abstract] [Full Text] [Related]

  • 11. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
    Gray RH, Campbell OM, Zacur HA, Labbok MH, MacRae SL.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
    [Abstract] [Full Text] [Related]

  • 12. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants.
    Benagiano G, Ermini M, Carenza L, Donini P.
    Acta Endocrinol (Copenh); 1973 Jun; 73(2):347-59. PubMed ID: 4740834
    [Abstract] [Full Text] [Related]

  • 13. Effects of long-term low-dose mifepristone on reproductive function in women.
    Croxatto HB, Kovács L, Massai R, Resch BA, Fuentealba B, Salvatierra AM, Croxatto HD, Zalányi S, Viski S, Krenács L.
    Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma levels of progesterone during the luteal phase in normal women treated with synthetic oestrogens (RS 2874, F 6103 and ethinyloestradiol).
    Johansson ED, Gemzell C.
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):551-60. PubMed ID: 5171371
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urinary hormone excretion patterns during low-dose progestogen administration.
    Varga L, Tamme E.
    J Int Med Res; 1975 Nov; 3(2):63-72. PubMed ID: 1140508
    [Abstract] [Full Text] [Related]

  • 19. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
    Blackwell LF, Vigil P, Alliende ME, Brown S, Festin M, Cooke DG.
    Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.